{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:16:51Z","timestamp":1720934211291},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11596-021-2367-5","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T15:04:11Z","timestamp":1623769451000},"page":"505-512","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression"],"prefix":"10.1007","volume":"41","author":[{"given":"Hui","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"9","key":"2367_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in china. N Engl J Med, 2016,375(9):905\u2013906","journal-title":"N Engl J Med"},{"issue":"1","key":"2367_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-015-3766-6","volume":"59","author":"R Bassi","year":"2016","unstructured":"Bassi R, Fornoni A, Doria A, et al. CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease. Diabetologia, 2016,59(1):21\u201329","journal-title":"Diabetologia"},{"issue":"7","key":"2367_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1681\/ASN.2012050445","volume":"24","author":"W Pichaiwong","year":"2013","unstructured":"Pichaiwong W, Hudkins KL, Wietecha T, et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol, 2013,24(7):1088\u20131102","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2367_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11596-009-0405-9","volume":"29","author":"X Sun","year":"2009","unstructured":"Sun X, Fang Z, Zhu Z, et al. Effect of down-regulation of TRPC6 on the puromycin aminonucleoside-induced apoptosis of mouse podocytes. J Huazhong Univ Sci Technolog Med Sci, 2009,29(4):417\u2013422","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"3","key":"2367_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11596-012-0059-x","volume":"32","author":"X Sun","year":"2012","unstructured":"Sun X, Chu Y, Zhang C, et al. Effect of TRPC6 knockdown on puromycin Aminonucleoside-induced podocyte injury. J Huazhong Univ Sci Technolog Med Sci, 2012,32(3):340\u2013345","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"3","key":"2367_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40256-018-00321-5","volume":"19","author":"Y Feng","year":"2019","unstructured":"Feng Y, Huang R, Kavanagh J, et al. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis. Am J Cardiovasc Drugs, 2019,19(3):259\u2013286","journal-title":"Am J Cardiovasc Drugs"},{"issue":"11","key":"2367_CR7","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/ndt\/gfy001","volume":"33","author":"J Cai","year":"2018","unstructured":"Cai J, Huang X, Zheng Z, et al. Comparative efficacy of individual renin-angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis. Nephrol Dial Transplant, 2018, 33(11):1968\u20131976","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2367_CR8","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1189\/jlb.3A0716-295RR","volume":"101","author":"C Mu","year":"2017","unstructured":"Mu C, Zhang X, Wang L, et al. Enhanced suppression of polyclonal CD8+ 25+ regulatory T cells via exosomal arming of antigen-specific peptide\/MHC complexes. J Leukoc Biol, 2017,101(5):1221\u20131231","journal-title":"J Leukoc Biol"},{"issue":"3","key":"2367_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cei.12723","volume":"183","author":"M Cai","year":"2016","unstructured":"Cai M, Zhou T, Wang X, et al. DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis. Clin Exp Immunol, 2016,183(3):317\u2013325","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2367_CR10","doi-asserted-by":"publisher","first-page":"F723","DOI":"10.1152\/ajprenal.00491.2018","volume":"316","author":"GS Netti","year":"2019","unstructured":"Netti GS, Sangregorio F, Spadaccino F, et al. LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis. Am J Physiol Renal Physiol, 2019,316(4):F723\u2013F731","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2367_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10157-017-1489-3","volume":"22","author":"B Khullar","year":"2018","unstructured":"Khullar B, Balyan R, Oswal N, et al. Interaction of CD80 with Neph1: a potential mechanism of podocyte injury. Clin Exp Nephrol, 2018,22(3):508\u2013516","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2367_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrneph.2013.276","volume":"10","author":"J Reiser","year":"2014","unstructured":"Reiser J, Alachkar N. Proteinuria: abate or applaud abatacept in proteinuric kidney disease? Nat Rev Nephrol, 2014,10(3):128\u2013130","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2367_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1152\/ajprenal.00184.2016","volume":"311","author":"SK Mallipattu","year":"2016","unstructured":"Mallipattu SK, He JC. The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Renal Physiol, 2016,311(1):46\u201351","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"2367_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nep.13463","volume":"23","author":"Y Liu","year":"2018","unstructured":"Liu Y, Shi Y, Ren R, et al. Advanced therapeutics in focal and segmental glomerulosclerosis. Nephrology (Carlton), 2018,23(4):57\u201361","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"2367_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1681\/ASN.2015080947","volume":"27","author":"DJ Salant","year":"2016","unstructured":"Salant DJ. Podocyte expression of B7-1\/CD80: Is it a reliable biomarker for the treatment of proteinuric kidney diseases with Abatacept?. J Am Soc Nephrol, 2016, 27(4):963\u2013965","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2367_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1681\/ASN.2015030266","volume":"27","author":"E Gagliardini","year":"2016","unstructured":"Gagliardini E, Novelli R, Corna D, et al. B7-1 Is not induced in podocytes of human and experimental diabetic nephropathy. J Am Soc Nephrol, 2016,27(4):999\u20131005","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2367_CR17","doi-asserted-by":"publisher","first-page":"0152315","DOI":"10.1371\/journal.pone.0152315","volume":"11","author":"J Norlin","year":"2016","unstructured":"Norlin J, Nielsen Fink L, Helding Kvist P, et al. Abatacept treatment does not preserve renal function in the streptozocin-induced model of diabetic nephropathy. PLoS One, 2016,11(4):0152315","journal-title":"PLoS One"},{"issue":"7","key":"2367_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1681\/ASN.2013050518","volume":"25","author":"P Fiorina","year":"2014","unstructured":"Fiorina P, Vergani A, Bassi R, et al. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol, 2014, 25(7):1415\u20131429","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2367_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-015-3766-6","volume":"59","author":"R Bassi","year":"2016","unstructured":"Bassi R, Fornoni A, Doria A, et al. CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease. Diabetologia, 2016,59(1):21\u201329","journal-title":"Diabetologia"},{"issue":"6","key":"2367_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40620-016-0296-3","volume":"29","author":"HZ Xu","year":"2016","unstructured":"Xu HZ, Wang WN, Zhang YY, et al. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. J Nephrol, 2016,29(6):775\u2013782","journal-title":"J Nephrol"},{"issue":"9","key":"2367_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fendo.2018.00418","volume":"24","author":"B Lewko","year":"2018","unstructured":"Lewko B, Maryn A, Latawiec E, et al. Angiotensin II modulates podocyte glucose transport. Front Endocrinol (Lausanne), 2018,24(9):418","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2367_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.biocel.2016.08.042","volume":"79","author":"HY Park","year":"2016","unstructured":"Park HY, Seong SB, Min SY, et al. CD2-associated protein\/phosphoinositide 3-kinase signaling has a preventive role in angiotensin II-induced podocyte apoptosis. Int J Biochem Cell Biol, 2016, 79(10):370\u2013381","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2367_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10157-012-0649-8","volume":"17","author":"JY Choi","year":"2013","unstructured":"Choi JY, Ha TS, Park HY, et al. Angiotensin D suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling. Clin Exp Nephrol, 2013,17(1):16\u201323","journal-title":"Clin Exp Nephrol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2367-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-021-2367-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2367-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T17:15:28Z","timestamp":1626023728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-021-2367-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2367"],"URL":"https:\/\/doi.org\/10.1007\/s11596-021-2367-5","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}